Biotynox® is the consumer quality leader!
Biotynox® has been awarded the consumer quality leader in the 2019 debut category. We are very pleased that our work is appreciated and noticed by patients.
Once again this year, we are launching new OTC medicines
This month, our brand new OTC medicines - Magnefar® B6 Forte and Magnefar® B6 Bio arrived at pharmacies in Poland. This is yet another success of Biofarm, responding to the needs of patients who suffer from fatigue, cramps and other symptoms of magnesium deficiency.
Unique dose of Nebivolol – 10 mg
Hypertension is the most important modifiable risk factor for cardiovascular diseases, and according to WHO is also the major cause of premature death in the world. Based on the NATPOL and WOBASZ II studies, it is estimated that currently in Poland hypertension affects 11 million patients, and by 2035 their number may increase by up to half.
Biofarm exhibited at CPHI Worldwide 2019 in Frankfurt
Last week we exhibited at CPhI Worldwide, the most important event on a global scale in the pharmaceutical industry.